• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

9.320 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4
Open 9.320
Bid (Size) 3.770 (100)
Ask (Size) 14.91 (200)
Prev. Close 9.320
Today's Range 9.320 - 9.320
52wk Range 4.300 - 9.510
Shares Outstanding 47,509,765
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Puma Biotechnology (PBYI) Q2 2026 Earnings Call Transcript ↗
August 14, 2026
NERLYNX demand surged 12% year over year as Puma raised full-year guidance. 
Via The Motley Fool
Topics Earnings
News headline image
Puma Biotechnology Q2 Earnings Call Highlights ↗
August 07, 2026
Puma Biotechnology (NASDAQ:PBYI) reported second-quarter 2026 total revenue of $56.5 million, including $53.6 million in net product revenue from NERLYNX and $2.9 million in royalty revenue. The... 
Via MarketBeat
Topics Earnings

Performance

YTD
+61.5%
+61.5%
1 Month
+16.6%
+16.6%
3 Month
+28.2%
+28.2%
6 Month
+24.4%
+24.4%
1 Year
+86.8%
+86.8%

More News

Read More
Puma Biotechnology (NASDAQ:PBYI) Beats Q2 Estimates, but Soft Q3 Guidance Tempers Reaction ↗
August 06, 2026
Via Chartmill
News headline image
Puma Biotechnology Reports Second Quarter 2026 Financial Results
August 06, 2026
From Puma Biotechnology, Inc.
Via Business Wire
PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) Beats Q1 Estimates, Raises Full-Year Guidance ↗
May 07, 2026
Via Chartmill
Puma Biotechnology (NASDAQ:PBYI) Beats Q4 Estimates, Guides for Profitable 2026 ↗
February 26, 2026
Via Chartmill
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
August 05, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results
July 23, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma (PBYI) Q1 2026 Earnings Call Transcript ↗
May 08, 2026
Via The Motley Fool
Topics Earnings
News headline image
Puma Biotechnology Q1 Earnings Call Highlights ↗
May 08, 2026
Via MarketBeat
Topics Earnings
News headline image
Puma Biotechnology Reports First Quarter 2026 Financial Results
May 07, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results
April 23, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? ↗
March 23, 2026
Via The Motley Fool
News headline image
Puma Biotech (PBYI) Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
News headline image
Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference
February 23, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
February 04, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
January 07, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
December 22, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2025
From Puma Biotechnology, Inc.
Via Business Wire

Frequently Asked Questions

Is Puma Biotechnology Inc - Common Stock publicly traded?
Yes, Puma Biotechnology Inc - Common Stock is publicly traded.
What exchange does Puma Biotechnology Inc - Common Stock trade on?
Puma Biotechnology Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Puma Biotechnology Inc - Common Stock?
The ticker symbol for Puma Biotechnology Inc - Common Stock is PBYI on the Nasdaq Stock Market
What is the current price of Puma Biotechnology Inc - Common Stock?
The current price of Puma Biotechnology Inc - Common Stock is 9.320
When was Puma Biotechnology Inc - Common Stock last traded?
The last trade of Puma Biotechnology Inc - Common Stock was at 08/25/26 04:00 PM ET
What is the market capitalization of Puma Biotechnology Inc - Common Stock?
The market capitalization of Puma Biotechnology Inc - Common Stock is 442.79M
How many shares of Puma Biotechnology Inc - Common Stock are outstanding?
Puma Biotechnology Inc - Common Stock has 443M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap